180 related articles for article (PubMed ID: 34239017)
1. Low expression of miR-29a is associated with aggressive biology and worse survival in gastric cancer.
Tokumaru Y; Oshi M; Huyser MR; Yan L; Fukada M; Matsuhashi N; Futamura M; Akao Y; Yoshida K; Takabe K
Sci Rep; 2021 Jul; 11(1):14134. PubMed ID: 34239017
[TBL] [Abstract][Full Text] [Related]
2. Reduced miR-29a-3p expression is linked to the cell proliferation and cell migration in gastric cancer.
Zhao Z; Wang L; Song W; Cui H; Chen G; Qiao F; Hu J; Zhou R; Fan H
World J Surg Oncol; 2015 Mar; 13():101. PubMed ID: 25889078
[TBL] [Abstract][Full Text] [Related]
3. lncRNA-MIAT regulates cell biological behaviors in gastric cancer through a mechanism involving the miR-29a-3p/HDAC4 axis.
Li Y; Wang K; Wei Y; Yao Q; Zhang Q; Qu H; Zhu G
Oncol Rep; 2017 Dec; 38(6):3465-3472. PubMed ID: 29039602
[TBL] [Abstract][Full Text] [Related]
4. Cell-derived microvesicles mediate the delivery of miR-29a/c to suppress angiogenesis in gastric carcinoma.
Zhang H; Bai M; Deng T; Liu R; Wang X; Qu Y; Duan J; Zhang L; Ning T; Ge S; Li H; Zhou L; Liu Y; Huang D; Ying G; Ba Y
Cancer Lett; 2016 Jun; 375(2):331-339. PubMed ID: 27000664
[TBL] [Abstract][Full Text] [Related]
5. MiR-652 serves as a prognostic biomarker in gastric cancer and promotes tumor proliferation, migration, and invasion via targeting RORA.
Li J; Zou X
Cancer Biomark; 2019; 26(3):323-331. PubMed ID: 31524147
[TBL] [Abstract][Full Text] [Related]
6. MiR-675 is frequently overexpressed in gastric cancer and enhances cell proliferation and invasion via targeting a potent anti-tumor gene PITX1.
Liu L; Tian YC; Mao G; Zhang YG; Han L
Cell Signal; 2019 Oct; 62():109352. PubMed ID: 31260797
[TBL] [Abstract][Full Text] [Related]
7. sMicroRNA-28-5p acts as a metastasis suppressor in gastric cancer by targeting Nrf2.
Yue CF; Li LS; Ai L; Deng JK; Guo YM
Exp Cell Res; 2021 May; 402(2):112553. PubMed ID: 33737068
[TBL] [Abstract][Full Text] [Related]
8. MiR-29a, targeting caveolin 2 expression, is responsible for limitation of pancreatic cancer metastasis in patients with normal level of serum CA125.
Liang C; Shi S; Meng Q; Liang D; Hua J; Qin Y; Zhang B; Xu J; Ni Q; Yu X
Int J Cancer; 2018 Dec; 143(11):2919-2931. PubMed ID: 29978477
[TBL] [Abstract][Full Text] [Related]
9. Expression and prognostic value of microRNA-26a and microRNA-148a in gastric cancer.
Qiu X; Zhu H; Liu S; Tao G; Jin J; Chu H; Wang M; Tong N; Gong W; Zhao Q; Qiang F; Zhang Z
J Gastroenterol Hepatol; 2017 Apr; 32(4):819-827. PubMed ID: 27529338
[TBL] [Abstract][Full Text] [Related]
10. miR-632 promotes gastric cancer progression by accelerating angiogenesis in a TFF1-dependent manner.
Shi Y; Huang X; Chen G; Wang Y; Liu Y; Xu W; Tang S; Guleng B; Liu J; Ren J
BMC Cancer; 2019 Jan; 19(1):14. PubMed ID: 30612555
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-509-3p Inhibits Cancer Cell Proliferation and Migration via Upregulation of XIAP in Gastric Cancer Cells.
Sun J; Li J; Zhang W; Zhang J; Sun S; Li G; Song H; Wan D
Oncol Res; 2017 Mar; 25(3):455-461. PubMed ID: 27697095
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-379 inhibits metastasis and epithelial-mesenchymal transition via targeting FAK/AKT signaling in gastric cancer.
Xu M; Qin S; Cao F; Ding S; Li M
Int J Oncol; 2017 Sep; 51(3):867-876. PubMed ID: 28713929
[TBL] [Abstract][Full Text] [Related]
13. MicroRNA-1 acts as a tumor suppressor microRNA by inhibiting angiogenesis-related growth factors in human gastric cancer.
Xie M; Dart DA; Guo T; Xing XF; Cheng XJ; Du H; Jiang WG; Wen XZ; Ji JF
Gastric Cancer; 2018 Jan; 21(1):41-54. PubMed ID: 28493075
[TBL] [Abstract][Full Text] [Related]
14. miR-506 Inhibits Epithelial-to-Mesenchymal Transition and Angiogenesis in Gastric Cancer.
Li Z; Liu Z; Dong S; Zhang J; Tan J; Wang Y; Ge C; Li R; Xue Y; Li M; Wang W; Xiang X; Yang J; Ding H; Geng T; Yao K; Song X
Am J Pathol; 2015 Sep; 185(9):2412-20. PubMed ID: 26362716
[TBL] [Abstract][Full Text] [Related]
15. miR-335 directly, while miR-34a indirectly modulate survivin expression and regulate growth, apoptosis, and invasion of gastric cancer cells.
Yang B; Huang J; Liu H; Guo W; Li G
Tumour Biol; 2016 Feb; 37(2):1771-9. PubMed ID: 26318298
[TBL] [Abstract][Full Text] [Related]
16. MicroRNA 495 Inhibits Proliferation and Metastasis and Promotes Apoptosis by Targeting Twist1 in Gastric Cancer Cells.
Liu C; Jian M; Qi H; Mao WZ
Oncol Res; 2019 Feb; 27(3):389-397. PubMed ID: 29615148
[TBL] [Abstract][Full Text] [Related]
17. Clinical significance of serum miR-25 as a diagnostic and prognostic biomarker in human gastric cancer.
Kong Y; Ning L; Qiu F; Yu Q; Cao B
Cancer Biomark; 2019; 24(4):477-483. PubMed ID: 30909187
[TBL] [Abstract][Full Text] [Related]
18. MiR-451, a potential prognostic biomarker and tumor suppressor for gastric cancer.
Su Z; Zhao J; Rong Z; Geng W; Wang Z
Int J Clin Exp Pathol; 2015; 8(8):9154-60. PubMed ID: 26464660
[TBL] [Abstract][Full Text] [Related]
19. Downregulation of miR-519a Predicts Poor Prognosis and Contributes to Tumor Progression in Gastric Cancer.
Cai H; Lin H; Cao W; Sun J; Huang Y; Fang Y
Oncol Res Treat; 2020; 43(1-2):19-26. PubMed ID: 31743914
[TBL] [Abstract][Full Text] [Related]
20. Increased expression of miR-181d is associated with poor prognosis and tumor progression of gastric cancer.
Li Z; Guo Q; Lu Y; Tian T
Cancer Biomark; 2019; 26(3):353-360. PubMed ID: 31524144
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
